Company Profile

Avid Bioservices Stock Price, News & Analysis

Ticker:
CDMO
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Why the stock is moving

Current closing-price context is not available for CDMO.

Company overview

Business overview

Avid Bioservices is a biologics manufacturing and development company that supports biopharma customers with contract production and process development.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Avid sits in contract biologics manufacturing.

Business Model Characteristics

Its revenue depends on manufacturing utilization, customer demand, and the health of outsourced biologics production.

Position Within the Biotechnology Landscape

Avid is part of the biotech manufacturing layer where execution and capacity utilization drive the story.

Future catalysts

Avid Bioservices's catalysts are biologics-manufacturing utilization, client wins, and any transaction or site-transfer milestone that clarifies the company's next phase. The market will care about whether the manufacturing footprint still has enough demand to justify a cleaner long-term profile.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What does Avid Bioservices do?

    Avid Bioservices is a biologics manufacturing and development company that supports biopharma customers with contract production and process development.

    On which exchange is CDMO stock listed?

    Avid Bioservices (CDMO) is associated with NASDAQ, United States, Biopharma.

    What is Avid?

    Avid Bioservices's catalysts are biologics-manufacturing utilization, client wins, and any transaction or site-transfer milestone that clarifies the company's next phase.

    Which conditions is Avid Bioservices targeting with Avid?

    Avid Bioservices's catalysts are biologics-manufacturing utilization, client wins, and any transaction or site-transfer milestone that clarifies the company's next phase.

    How does Avid Bioservices describe recent progress with Avid?

    Avid Bioservices's catalysts are biologics-manufacturing utilization, client wins, and any transaction or site-transfer milestone that clarifies the company's next phase.

    What is Bioservices?

    Avid Bioservices is a biologics manufacturing and development company that supports biopharma customers with contract production and process development.

    What should investors watch for with Bioservices?

    Avid Bioservices's catalysts are biologics-manufacturing utilization, client wins, and any transaction or site-transfer milestone that clarifies the company's next phase.

    What future catalysts are investors watching for Avid Bioservices?

    Avid Bioservices's catalysts are biologics-manufacturing utilization, client wins, and any transaction or site-transfer milestone that clarifies the company's next phase. The market will care about whether the manufacturing footprint still has enough demand to justify a cleaner long-term profile.